Addiction Science & Clinical Practice · 2021 · 13 citations · 27 references
NursingFamily MedicinePharmacotherapyClinical Decision SupportPrimary CareSubstance Use DisordersDecision Support In HealthcareMedication-assisted TreatmentOpioid AnalgesicsOpioid ManagementOpioid TherapyOpioid Use DisorderBuprenorphine TreatmentClinical Decision Support ModelsClinical Decision Support ToolsOffice-based Opioid TreatmentOpioid Analgesic ManagementPrescription Decision SupportTreatment Capacity AssessmentTreatment Capacity Planning
BACKGROUND: The treatment capacity for opioid use disorder (OUD) lags far behind the number of patients in need of treatment. Capacity is limited, in part, by the limited number of physicians who offer office based OUD treatment with buprenorphine. Measurement based care (MBC) has been proposed as a means to support primary care physicians in treating OUD. Here, we propose a set of measures and a clinical decision support algorithm to provide MBC for the treatment of OUD. METHODS: We utilized literature search and expert consensus to identify measures for universal screening and symptom tracking. We used expert consensus to create the clinical decision support algorithm. RESULTS: The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool was selected as the best published measure for universal screening in primary care. No published measure was identified as appropriate for symptom tracking or medication adherence; therefore, we created the OUD Symptom Checklist from the DSM-5 criteria for OUD and the Patient Adherence Questionnaire for Opioid Use Disorder Treatment (PAQ-OUD) to assess medication adherence. We developed and present a clinical decision support algorithm to provide direct guidance regarding treatment interventions during the first 12 weeks of buprenorphine treatment. CONCLUSION: Creation of these tools is the necessary first step for implementation of MBC for the treatment of OUD with buprenorphine in primary care. Further work is needed to test the feasibility and acceptability of these tools. Trial Registration ClinicalTrials.gov; NCT04059016; 16 August 2019; retrospectively registered; https://clinicaltrials.gov/ct2/show/NCT04059016.
27
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
Rose A. Rudd, Puja Seth, Felicita David et al. · MMWR Morbidity and Mortality Weekly Report · 2016 · 2.2K citations · Full text
Pharmacy, Pharmacology, Toxicology +16
Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 699 citations · Full text
AMERICAN SOCIETY OF ADDICTION MEDICINE
Journal of Addictive Diseases · 2003 · 550 citations
A Single-Question Screening Test for Drug Use in Primary Care
Peter Smith, Susan Schmidt, Donald Allensworth‐Davies et al. · Archives of Internal Medicine · 2010 · 487 citations · Full text